20624

Sclareol glycol, a diterpene diol, is utilized as a precursor in the synthesis of ambroxide. It is characterized by a specific stereochemistry at its (3S,6R,8aS)-configurations, with two hydroxyl groups attached at the [2R,3aR,6S,8aR]-octahydro-3a,6,6,8a-tetramethyl-2-(1-methylethyl) perhydrophenanthrene framework.

Bitriben is an agent with the anthelmintic effect.

Lp(a)-IN-6 (Compound 6) is an inhibitor of lipoprotein (a) [Lp(a)], exhibiting an IC50 value of less than 0.314 nM. It is utilized in research related to cardiovascular diseases (CVD).

ASK1-IN-8 (Compound 35) is an orally active inhibitor of apoptosis signal-regulating kinase 1 (ASK1) with an IC50 value of 1.8 nM. In a mouse liver injury model induced by Acetaminophen, ASK1-IN-8 significantly reduces plasma alanine aminotransferase (ALT) levels, offering liver protection. This compound is useful for research in liver disease-related fields.

Solanezumab (LY 2062430) is a monoclonal antibody that binds preferentially to soluble amyloid and promotes its clearance from the brain.Solanezumab is used in the study of Alzheimer's disease.

Sodium diethylcarbamodithioate trihydrate, ACS, 99.0% (Ditiocarb sodium trihydrate, ACS, 99.0%), is a copper reagent that reacts with Cu2+ solutions to form complexes, enhancing the rate of copper precipitation. Additionally, it has potential in reducing HIV infection and is employed in adjuvant immune research for high-risk breast cancer.